White Paper: Pharmacovigilance in HCP social media listening

A guide for Drug Safety professionals, and anybody involved in scoping or approving social media listening projects with healthcare professionals.

Fill out your details below to receive your copy of this Whitepaper for simple tools to inform constructive conversations with your colleagues in market research, or digital marketing, or brand teams, about their social media listening.

Related Resources

27.11.2023 | Whitepaper

White Paper: The barriers facing RSV vaccine launches

Never before seen insights from HCPs' online conversations in RSV

24.11.2023 | Article

eHCPs are overwhelmingly against charging for the use of X

eHCPs express their opposition towards Elon Musk's decision to begin charging X users

By Cameron Bassindale and Jamie Doggett

21.11.2023 | Webinars

What to expect in 2024

The learnings from 2023 shaping innovations in pharma HCP engagement

By Daniel Ghinn and Cameron Bassindale

21.11.2023 | Webinars

The 2023 Digital HCP Review

Celebrating and learning from the online HCP community

By Daniel Ghinn and Anni Neumann

10.11.2023 | Article

EASD 2023: what drove online conversation among HCPs and people with diabetes?

There were hundreds of presentations, posters and spotlight talks over the five days

By Jamie Doggett

02.11.2023 | Article

Top 50 Pharma Tracker: Novavax FDA approval received positively by eHCPs

Pfizer, Moderna, Novavax, Johnson & Johnson, and AstraZeneca were the most discussed by HCPs

By Aman Jandu